Sponsored Webcast: Planning for a Successful Initial IND and Moving Beyond: Regulatory CMC Considerations for Biotherapeutics and Cell and Gene Therapies
Tuesday, 19 Sep 2023 | 11:00 AM Eastern Time (US & Canada)
Sponsored Webcast: Planning for a Successful Initial IND and Moving Beyond: Regulatory CMC Considerations for Biotherapeutics and Cell and Gene Therapies
10th Annual Medtech & Pharma Platform (MPP) Conference
July 21, 2023
Therapeutic Innovation with Combined Products - Better Healthcare to Patients
Join Veristat and SFL, a Veristat company, at the Medtech & Pharma Platform's 10th Annual Conference, on 27th September 2023 in Basel, Switzerland.
BIOSPAIN 2023
July 18, 2023
Meet Veristat in Barcelona at BIOSPAIN 2023, 26-28 September 2023
Veristat and CITELINE hosted a webinar on the topic: Single-Arm Studies for Use as a Registrational Study in Oncology
Webinar | Impact of New Medical Device EU Regulation (MDR) on the Development of Drug-Device Combination Products
May 10, 2023
Veristat and TOPRA hosted a webinar on the topic: Impact of New EU Regulations on the Development of Medical Devices and Drug Combination Products
Bio Asia 2023
May 2, 2023
Meet Veristat at the Bio Asia Taiwan 2023 taking place on the 26-30 July 2023
MedTech Forum 2023
April 28, 2023
Meet Veristat at the MedTech Forum 2023 taking place on the 30th May – 1st June 2023
OCT Conference 2023
April 28, 2023
Meet Veristat at the Outsourcing in Clinical Trials Europe 2023 taking place on the 3th - 4th May 2023
Marcus Evans Evolution Summit May 2023
April 20, 2023
Meet with Shaheen Limbada, EVP Innovation and Strategy at the Evolution Summit
ASGCT Annual Meeting 2023
April 18, 2023
Veristat’s John Balser, PhD., will be presenting in the scientific symposium